Holen Sie sich die Stockscreener-App
1.69
0.00%
0.00
Neuroone Medical Technologies Corp Aktie (NMTC) Neueste Nachrichten
NeuroOne CBO David Wambeke buys $66,999 in company stock By Investing.com - Investing.com Australia
NeuroOne CBO David Wambeke buys $66,999 in company stock - Investing.com
NeuroOne (NMTC) CFO gets 35,000 options at $1.77 - Stock Titan
NeuroOne (NMTC) grants officer options at $1.77 - Stock Titan
NeuroOne Medical (NMTC) CEO granted 68K stock options - Stock Titan
Neuroone Medical Technologies Corp (NMTC) Key Financial Ratios – Valuation, Profitability & More - Value Research
NeuroOne Expects First StereoCED Revenue in Current Quarter - Minichart
NeuroOne reports successful large-animal StereoCED procedures, expects related revenue in Q4 2026 - TradingView
NeuroOne Medical | 8-K: Current report - Moomoo
NeuroOne (NMTC) Q3 2026 Earnings Call Transcript - The Globe and Mail
JonesTrading Maintains NeuroOne Medical(NMTC.US) With Buy Rating, Maintains Target Price $8 - Moomoo
NeuroOne Medical Technologies Corp (NMTC) (Q3 2026) Earnings Cal - GuruFocus
Neuroone Medical earnings missed by $0.10, revenue fell short of estimates - Investing.com
NMTC Maintained by Maxim Group -- Price Target Lowered to $5.00 - GuruFocus
NeuroOne (NMTC) Earnings Call zum 3. Quartal des Geschäftsjahres 2026: Aufträge steigen um 43 %, Marge erreicht 59,9 % - TradingKey
NeuroOne Medical Technologies Corporation Q3 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: NeuroOne Medical posts Q3 2026 revenue growth as shares fall - Investing.com
Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com Australia
Is NeuroOne Medical Technologies Corp (NMTC) Positioned for Grow - GuruFocus
NEUROONE MEDICAL TECHNOLOGIES Corp 3Q FY2026: Revenue $1.97M, EPS $(0.28) — 10-Q Summary - TradingView
Q3 2026 NeuroOne Medical Technologies Corp Earnings Call Transcript - GuruFocus
NeuroOne posts Q3 FY2026 revenue up 16% to $2.0M; gross margin expands to 59.9% - TradingView
NeuroOne Medical Technologies (NASDAQ: NMTC) posts larger loss and flags going concern risk - Stock Titan
NeuroOne Fiscal Q3 2026 Earnings: Gross Margin Expands as Net Loss Widens - TradingKey
NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9% - Yahoo Finance
NeuroOne(R) Achieves Major Milestone With ISO 13485 Certification - Yahoo Finance
Calendrier des fractionnements d'actions pour: - Yahoo Finance France
NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time - finance.yahoo.com
NeuroOne Medical Technologies Corp - tradingkey.com
NeuroOne Releases CNS Drug Delivery White Paper Ahead of Planned Fiscal Year-End Availability of the StereoCED(TM) Platform - Yahoo Finance
NeuroOne(R) Highlights Potential Paradigm Shift for Patients Treated With the OneRF(R) Brain Ablation System Based on Reports by Physicians - Yahoo Finance
NeuroOne Medical Technologies Corp (NMTC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Cash Flow - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NMTC|NeuroOne Medical Technologies Corp|Price:1.900|Chg%:+0.050 - TradingKey
NMTC|NeuroOne Medical Technologies Corp|Price:1.630|Chg%:+0.080 - TradingKey
AZIO Stock Price and Chart — NASDAQ:AZIO - tradingview.com
NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial - Yahoo Finance
Brian and Barbara Pratt disclose 12.5% NeuroOne stake (NASDAQ: NMTC) - Stock Titan
NeuroOne Medical Technologies (NMTC) Brian Pratt reports 1,085,934 shares - Stock Titan
Insider Sell: Mark Christianson Sells 10,000 Shares of NeuroOne Medical Technologies Corp (NMTC) - GuruFocus
NMTC (NMTC) director sells 10,000 shares, retains 20,692 after trade - Stock Titan
NeuroOne Medical Technologies Corp. Hits New 52-Week Low at $2.93 - MarketsMojo
Form 144 NEUROONE MEDICAL TECHNOLOGIES Corp For: 30 June - Investing.com UK
NeuroOne Medical Technologies (NMTC) Weighs on Support After 4.58% DeclineSign of Strength - dars.gov.et
Form 144 NEUROONE MEDICAL TECHNOLOGIES Corp For: 30 June By Investing.com - Investing.com South Africa
[144] NEUROONE MEDICAL TECHNOLOGIES Corp SEC Filing - Stock Titan
NeuroOne(R) Added to Russell Microcap(R) Index - Yahoo Finance
Form DEF 14A Neuroone Medical Technologies Corp For: 26 June By Investing.com - Investing.com South Africa
NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail
NMTC Should I Buy - Intellectia AI
NeuroOne Medical Technologies Corp. Hits 52-Week Low at $3.16 Amid Challenges - MarketsMojo
NeuroOne Medical Technologies Corp (NMTC) Institutional Confidence - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Valuation: PE, PB & Fair Value Analysis - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
0.25%
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):